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Executive Summary 
 
The MultiSim programme (sponsored by EPSRC under its Frontier Engineering Awards) held 
a two-day workshop to discuss the opportunities and technological challenges associated 
with modelling the neuromusculoskeletal (MSK) system. The workshop was attended by 40 
participants from the UK MSK community including leading academics from 15 UK 
Universities, industrial representatives, key individuals from EPSRC, and several clinicians 
from Sheffield Teaching Hospitals.  
 
MSK research has made significant progress in the last 5-10 years thanks in particular to the 
development of new computational modelling techniques and the intensified use of clinical 
imaging data. This has led to the development of multiscale models that include more and 
more personalisation about the patient. Such models have enabled for example, much more 
accurate predictions of the risk of bone fracture in osteoporotic patients and helped 
surgeons to decide the optimal treatment for lower back pain in a patient-specific manner. 
In the future, the use of such personalised medicine and multiscale models will intensify to 
provide more accurate clinical tools and reduce the costs associated with diagnosis, 
treatment and monitoring of patients.  
 
With the integration of complex biological and physical processes, more transdisciplinarity 
between engineers, clinicians and biologists is required. This means that more efforts are 
needed to provide such interdisciplinary training at all levels and to facilitate clinicians to 
perform research. There is a risk of seeing those scientific and clinical progresses being 
hindered by the lack of adequate infrastructure that enables testing and validation of our 
MSK system, and that can handle the integration of large patient data in a seamless manner 
for the researcher, while preserving the anonymity of the patient. It was recognised that the 
MSK community needs to have a bigger say at the national level to adequately formulate the 
importance of MSK disorders within society and highlight the necessity of being included in 
discussions on the modernisation of the healthcare system.  It was concluded that a MSK 
network within UK should be developed as a result of this workshop. The outcomes from 
this workshop are well aligned with the research focus and strategic challenges outlined by 
several key funding bodies. 
 
Findings 
 
The workshop was scheduled on 7 October 2014 at the University of Sheffield and included 
interactive sessions where participants could provide valuable input on three key topic 
areas: (i) scientific opportunities in multiscale modelling of the MSK system; (ii) the current 
technological challenges; and (iii) external constraints associated with the research. This 
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report presents the outcomes of the workshop, compiled from written and verbal feedback 
from participants. 
 
(i) Scientific opportunities in multiscale modelling of the MSK system 
 
Within the last 5 years research in the musculoskeletal area has made significant advances, 
in particular in the ability to use advanced imaging techniques to derive accurate patient-
specific computational models. Many computational models are based on in vivo and clinical 
imaging used for pre-clinical and clinical tests. Such advances have enable us to progress 
towards the use of computational models for clinical practice, with models being used for 
risk predictions and multiscale modelling being used to identify problems in joint 
replacement (such as total knee replacement, total hip replacement or treatment of lower 
back pain). These advancements were helped with the availability of high performance 
computers for complex simulations and the increased accessibility of open simulation 
software. 
 
In the next 10 years further effort must be directed towards personalised strategies, in 
particular identification and prediction of patients at risk, and diagnosing appropriate 
intervention for that patient. Computational models can be used to improve the reliability of 
implants and joint replacement, increase their longevity, and improve their efficiency in 
relieving pain. In addition to efforts towards the improvement of orthopaedic solutions, 
more patient-specific tissue engineering research is also needed. The diagnosis, treatment 
and monitoring of MSK disorders (such as osteoporosis, oesto/arthritis, back and neck pain, 
injuries, obesity, and metabolic syndrome) through the development of patient-specific 
computational models need to be integrated with sensing technology and clinical support in 
order to improve patient outcomes, self-management, and exercise. Other areas include 
improved animal models with more relevant outcomes in humans, biomarkers for targeted 
intervention, infection control, and improving knowledge about rare bone diseases where 
the numbers are low, but the impact is high.  
 
In order to reach this 10-year vision a number of capability and skills are needed. First, a 
greater transdisciplinary approach, with biologists, clinicians and engineering working 
together at all stages of research in a collaborative environment. There is a requirement for 
students and researchers to be trained in multiple disciplines to bridge the gap between 
these three areas. Such multi- and inter-disciplinary approach will ease the integration of 
software solution to the clinics, providing a tool for the clinicians to treat their patients. As 
the models rely more and more on personalised data, the community needs to also embrace 
and participate in the development of big data initiatives where the sensitivity of clinical 
data makes the infrastructure specific to healthcare. Thus, leadership is needed to help raise 
the profile and recognition of MSK issues, such as the cost of MSK related disorders. Lessons 
could be learnt from other systems communities that have effective established networks 
(such as cardiology). Finally, a centralisation of our key facilities, such as a large animal 
centre and implant centres, in the UK or Europe, is required for interactions with industry. 
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There is a skills-gap at undergraduate (UG) level. Key skills missing include coding, linking 
modelling and experiments, monitoring and testing (with equal competence in each), and 
software development. The introduction of bioengineering degrees have encouraged more 
people into the field, but the UG courses do not always provide the depth that is required; 
masters-level training is therefore necessary to achieve this depth. More specialised courses 
for UG students could improve this, for example systems engineering in bioengineering, 
placements, intercalated students, and also projects to bring together undergraduates from 
bioscience and engineering. The four-year PhD as established in the CDTs is useful to achieve 
such multidisciplinary training. Focus should be made on enhancing interactions between 
engineering PhD students and clinicians, as well as modelling and imaging students. It is 
important to attract the best students, including international PhD students. Such 
multidisciplinary training should continue at all levels, with disciplinary hoping and longer 
term fellowships. There is a need for a mixture of super specialised researchers and more 
generalised coordinators. 
 
 
(ii) Technological challenges associated to multiscale modelling of the MSK system 
 
The ability to generate complex models for single scales, inverse dynamics and finite 
element modelling, proper model validation (at least at the organ or body level), and image 
processing are all strengths within the MSK community. However, there are a number of 
technological challenges that have been identified, which need to be addressed in order to 
reach our scientific vision. The main issues are the complexity of the modelling with the 
inherent multiscale properties, uncertainty and variability of the system. There is 
opportunity to learn from other fields, where there are similar complexity issues. Examples 
include consumer goods, self-heating materials, aerospace and the food industry, who are 
embracing simulations more and more; also software industries such as computer graphics, 
where they use advanced finite element analysis, and non-invasive tomography techniques 
used in other fields could be applied to MSK research. Surrogate and uncertainty modelling 
are a strength in other areas, for example representing exterior load variation and 
mechanical responses using stochastic finite element models. Although, it would be a 
challenge to transfer these technologies to the MSK field. Other areas are more effective at 
continuously monitoring people and coping with the large amount of data generated. 
Handling a large volume of different data types was identified as a problem, along with the 
issue of data protection. Obtaining data, and sharing data and databases needs to be 
improved to make useful data available to the community. A single framework to allow data 
to be shared between people may be one solution, although there was no universal 
agreement on this point. There is a lack of awareness of the importance of data for research 
and ethics/consent. One of the possible solutions to ease the access of data is to enable 
clinicians to perform more research within the clinical workload. This will also facilitate the 
collaboration between academics, industry and clinicians to help in the design of devices and 
improve the patient planning process. Currently there is a gap between basic research and 
the point where the product is mature enough for industry to invest. This area has a lot of 
potential, but there has to be a mechanism to fill the gap. 
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To circumvent these challenges, one of the key infrastructure challenges will be data 
handling. There is a lack of infrastructure to analyse clinical data and report it back for 
clinical use, as well as the need for an infrastructure for sharing of data and models across 
institutions. Attention must be paid on quality control and clear instructions on shared data 
to prevent a mistrust of data collected by other researchers. Incentives may be important to 
encourage full release of data and models. In terms of skills, there is a need to have 
engineers with improved coding skills to create better tools at all levels. Also engineers that 
have a better understanding of medical approaches, medical methods and numerical 
methods, with more communication between clinicians, engineers and scientists. One 
aspect that hinders the sharing of data is also the lack of standardised data formats from 
different manufacturers’ equipment. In terms of infrastructure it was identified that 
centralisation of large equipment was required, but these can be difficult to setup due to the 
co-funding requirement and new technologies need to be developed to make the transport 
of experimental material from one lab to another easier and more reliable. Manufacturers 
working directly with researchers, in particular to help with regulatory requirements that 
need to be met for specific devices, and a platform for communication on equipment 
development would be beneficial. 
 
 
(iii) External constraints associated to multiscale modelling of the MSK system 
 
There are other external constraints that need to be considered within the 10-year 
vision. This includes the difficulty in engaging the NHS in research, because in most Trusts 
the management model is not research oriented with high security, administrative and 
safety regulations. In Scotland, all clinical data is linked to the GP so there is an integrated 
clinical traceability. There was a concern that if the privatisation of the NHS continues, it will 
limit the ability to access information for clinical research. There is a lack of time and 
national policy for clinicians engaged in research. It is recognised that the MSK community 
needs to improve its advocacy at the government policy level so that MSK research is given 
more importance. In relation to this, there is a need to raise public awareness of MSK 
diseases, as it is not currently seen as a national issue. Also, it is important to participate in 
the discussion with the public on the benefits of sharing clinical data while at the same time 
ensuring that adequate firewalls are put into place to ensure privacy and integrity of the 
personal data. Current ethics limit the use of data to a particular project and prevent the 
reuse of data. There is a need to work together to get ethical approval to share the data and 
have continued use. Finally there are not sufficient incentives for home graduates to get into 
research, which prevent the development of a strong research-led innovation at the 
academic and industry sectors. 
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Workshop participants 
 
First Name Last name Organisation 
Richard Aspden University of Aberdeen 
Nick Bishop University of Sheffield 
Darren  Burke Bose Limited 
Sarah Cartmell University of Manchester 
Martin Champion EPSRC 
Yuhang  Chen Heriot-Watt University 
Enrico Dall’Ara University of Sheffield 
Clint Davis-Taylor Dassault Systemes Limited 
René De Borst University of Glasgow 
David Farrar Smith & Nephew 
Richie Gill University of Bath 
Nicolas  Gruel University of Sheffield 
Lingzhong Guo University of Sheffield 
Markus Heller University of Southampton 
Cathy Holt Cardiff University 
Visakan  Kadirkamanathan University of Sheffield 
Jan Herman Kuiper Keele University 
Damien Lacroix University of Sheffield 
Alex Lennon Queen’s University Belfast 
Xinshan  Li University of Sheffield 
Georges Limbert University of Southampton 
Claudia Mazzà University of Sheffield 
Sanjeev Madan Sheffield Children’s NHS Foundation Trust 
Victoria Marlow EPSRC 
Alan Monk Nikon Instruments 
Rajshree Mootanah Anglia Ruskin University 
Niamh Nowlan Imperial College London 
Alex Pavic University of Exeter 
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Cecile Perrault University of Sheffield 
Andrew Phillips Imperial College London 
Jeremy Purches NVIDIA Limited 
Vitomir Racic University of Sheffield 
Gwen Reilly University of Sheffield 
Michel Rochette Ansys 
Julia Shelton Queen Mary, University of London 
Tim Simpson Nikon Instruments 
Alison Traynor Corin Limited 
Marco Viceconti University of Sheffield 
Jennifer Walsh University of Sheffield 
Ruth Wilcox University of Leeds 
 
 
 
 
